TWIIST

Serial Number 97979283
807

Registration Progress

Application Filed
Feb 27, 2023
Under Examination
Apr 23, 2024
Approved for Publication
Feb 7, 2024
Published for Opposition
Feb 27, 2024
Registered

Trademark Image

TWIIST

Basic Information

Serial Number
97979283
Filing Date
February 27, 2023
Published for Opposition
February 27, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
807
Status Date
Jan 13, 2025
Application
Pending
Classes
005 010 041 042
+1 more

Rights Holder

DEKA Research & Development Corp.

03
Address
340 Commercial Street
Manchester, NH 03101

Ownership History

DEKA Research & Development Corp.

Original Applicant
03
Manchester, NH

DEKA Research & Development Corp.

Owner at Publication
03
Manchester, NH

Legal Representation

Attorney
Mark E. Tetreault

USPTO Deadlines

All Deadlines Cleared

All 6 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

43 events
Date Code Type Description
Jan 13, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2025 GNRT O NON-FINAL ACTION E-MAILED
Jan 13, 2025 CNRT W SU - NON-FINAL ACTION - WRITTEN
Nov 18, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Nov 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE
Nov 18, 2024 EX1G S SOU EXTENSION 1 GRANTED
Oct 7, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 7, 2024 IROA I RESPONSE TO ITU OFFICE ACTION ENTERED
Oct 5, 2024 INCD O ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Sep 20, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 2, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 2, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED
Jul 2, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 2, 2024 IUAF S USE AMENDMENT FILED
Jul 2, 2024 DRRR I DIVISIONAL REQUEST RECEIVED
Jul 2, 2024 EXT1 S SOU EXTENSION 1 FILED
Apr 23, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 27, 2024 PUBO A PUBLISHED FOR OPPOSITION
Feb 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Jan 24, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED
Jan 24, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2024 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 19, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 1, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2023 GNRT F NON-FINAL ACTION E-MAILED
Nov 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2023 CNRT R NON-FINAL ACTION WRITTEN
Nov 28, 2023 DOCK D ASSIGNED TO EXAMINER
Jul 10, 2023 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 10, 2023 ALIE A ASSIGNED TO LIE
Mar 17, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2023 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 2, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape, and adhesive bandages for use with infusion pumps and associated devices
First Use Anywhere: Jun 21, 2024
First Use in Commerce: Jun 21, 2024
Class 010
Medical devices, namely, infusion and injection devices for administering drugs, and pouches and mounts used therewith; medical devices, namely infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical apparatus for monitoring blood analyte levels; implantable subcutaneous drug delivery devices, sold empty in the nature of medical field injectors; on-body medical fluid injectors; chronic disease management devices, in the nature of medical sensors that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor
First Use Anywhere: Jun 21, 2024
First Use in Commerce: Jun 21, 2024
Class 041
Educational services, namely, creating and developing web-based and in-person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets
First Use Anywhere: Jun 21, 2024
First Use in Commerce: Jun 21, 2024
Class 042
Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD)
First Use Anywhere: Jun 21, 2024
First Use in Commerce: Jun 21, 2024
Class 044
Interactive medical monitoring and alert services for reminding infusion pump users of medicial dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users in the form of reports in the field of chronic disease managment; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; providing online searchable medical databases in the field of chronic disease management for patients, their family and caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease
First Use Anywhere: Jun 21, 2024
First Use in Commerce: Jun 21, 2024

Additional Information

Design Mark
The mark consists of the word "TWIIST" in stylized lettering with two pairs of semi-circular arcs extending above and below the word from the initial "T" to each of the "I"s.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
TWIST

Classification

International Classes
005 010 041 042 044

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO